Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VON LILIENFELD-TOAL, Marie")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 22 of 22

  • Page / 1
Export

Selection :

  • and

An evidence based review of the available antibiotic treatment options for neutropaenic patients and a recommendation for treatment guidelinesGLASMACHER, Axel; VON LILIENFELD-TOAL, Marie.International journal of infectious diseases. 2006, Vol 10, issn 1201-9712, S9-S16, SUP2Conference Paper

Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for δ2 γ/δ T cellsMÄRTEN, Angela; VON LILIENFELD-TOAL, Marie; BÜCHLER, Markus W et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 4, pp 370-377, issn 1524-9557, 8 p.Article

Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicityMÄRTEN, Angela; VON LILIENFELD-TOAL, Marie; BÜCHLER, Markus W et al.International journal of cancer. 2006, Vol 119, Num 10, pp 2359-2365, issn 0020-7136, 7 p.Article

A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapyVON LILIENFELD-TOAL, Marie; HAHN-AST, Corinna; KIRCHNER, Hartmut et al.Haematologica (Roma). 2007, Vol 92, Num 12, pp 1719-1720, issn 0390-6078, 2 p.Article

Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006HAHN-AST, Corinna; GLASMACHER, Axel; MÜCKTER, Sara et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 4, pp 761-768, issn 0305-7453, 8 p.Article

Novel treatment concepts for graft-versus-host diseaseWOLF, Dominik; VON LILIENFELD-TOAL, Marie; WOLF, Anna Maria et al.Blood. 2012, Vol 119, Num 1, pp 16-25, issn 0006-4971, 10 p.Article

Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis CNATTERMANN, Jacob; ZIMMERMANN, Henning; IWAN, Agathe et al.Hepatology (Baltimore, Md.). 2006, Vol 44, Num 4, pp 945-954, issn 0270-9139, 10 p.Article

A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myelomaGLASMACHER, Axel; HAHN, Comma; HOFFMANN, Florian et al.British journal of haematology. 2006, Vol 132, Num 5, pp 584-593, issn 0007-1048, 10 p.Article

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cellsMÄRTEN, Angela; RENOTH, Sabine; VON LILIENFELD-TOAL, Marie et al.Haematologica (Roma). 2001, Vol 86, Num 10, pp 1029-1037, issn 0390-6078Article

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linkedVON LILIENFELD-TOAL, Marie; FRANK, Susanne; COOK, Gordon et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 6, pp 829-839, issn 0340-7004, 11 p.Article

CD4+CD25+FoxP3+ regulatory T cells are increased whilst CD3+CD4-CD8-αβTCR+ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burdenFEYLER, Sylvia; VON LILIENFELD-TOAL, Marie; JARMIN, Sarah et al.British journal of haematology. 2009, Vol 144, Num 5, pp 686-695, issn 0007-1048, 10 p.Article

Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile NeutropeniaVON LILIENFELD-TOAL, Marie; LEHMANN, Lutz E; STUBER, Frank et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 8, pp 2405-2410, issn 0095-1137, 6 p.Article

Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myelomaPALUMBO, Antonio; DIMOPOULOS, Meletios; SAN MIGUEL, Jesus et al.Blood reviews. 2009, Vol 23, Num 2, pp 87-93, issn 0268-960X, 7 p.Article

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLKAYSER, Sabine; DÖHNER, Konstanze; RUMMEL, Mathias et al.Blood. 2011, Vol 117, Num 7, pp 2137-2145, issn 0006-4971, 9 p.Article

High-Dose Daunorubicin in Older Patients with Acute Myeloid LeukemiaLÖWENBERG, Bob; OSSENKOPPELE, GertJ; BIEMOND, Bart J et al.The New England journal of medicine. 2009, Vol 361, Num 13, pp 1235-1248, issn 0028-4793, 14 p.Article

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeRÜCKER, Frank G; SCHLENK, Richard F; PASCHKA, Peter et al.Blood. 2012, Vol 119, Num 9, pp 2114-2121, issn 0006-4971, 8 p.Article

Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupKRÖNKE, Jan; SCHLENK, Richard F; SPÄTH, Daniela et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2709-2716, issn 0732-183X, 8 p.Article

Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)PASCHKA, Peter; JUAN DU; GANSER, Arnold et al.Blood. 2013, Vol 121, Num 1, pp 170-177, issn 0006-4971, 8 p.Article

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study GroupGAIDZIK, Verena I; PASCHKA, Peter; BENTZ, Martin et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1350-1357, issn 0732-183X, 8 p.Article

Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid LeukemiaLUGTHART, Sanne; GRÖSCHEL, Stefan; VERHOEF, Gregor et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3890-3898, issn 0732-183X, 9 p.Article

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesKAYSER, Sabine; ZUCKNICK, Manuela; GERMING, Ulrich et al.Blood. 2012, Vol 119, Num 2, pp 551-558, issn 0006-4971, 8 p.Article

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 studyLÖWENBERG, Bob; BECK, Joachim; BIEMOND, Bart J et al.Blood. 2010, Vol 115, Num 13, pp 2586-2591, issn 0006-4971, 6 p.Article

  • Page / 1